INN name:
|
Apalutamide
|
||||||||||||
Lab codes:
|
ARN-509;
JNJ-56021927; JNJ-927
|
||||||||||||
Chemical
name:
|
4-{7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl}-2-fluoro-N-methylbenzamide
|
||||||||||||
Molecular
formula:
|
C21H15F4N5O2S
|
||||||||||||
Chemical
Structure:
|
|||||||||||||
CAS Registry
Number:
|
956104-40-8
|
||||||||||||
Originator:
|
University
of California System
|
||||||||||||
Developer:
|
Janssen
Research & Development
|
||||||||||||
Class:
|
Antiandrogens
|
||||||||||||
Mechanism of
Action:
|
Androgen
receptor antagonists; Hormone inhibitors
|
||||||||||||
WHO ATC code:
|
L02B-B
(Anti-androgens)
|
||||||||||||
EPhMRA code:
|
L2B2
(Cytostatic anti-androgens)
|
||||||||||||
Clinical Trials:
|
|||||||||||||
Product Patent Expiry:
For patent data contact
us at drugpatentexpiry@gmail.com
|
|||||||||||||
|
Tuesday, 8 September 2015
Apalutamide
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment